Overview
This webinar helps understand and simplify the diagnosis of severe asthma in your patients and explores the role of various biologics with a focus on Omalizumab in the management of severe asthma patients.
Faculty
Dr. Pralhad Prabhudesai
MBBS, MD (Chest Medicine) DNB (Chest Medicine), FCCP USA
Consultant Pulmonologist Lilavati Hospital Mumbai, India
Dr Raja Dhar
MBBS (Cal), MD (Respiratory Medicine), MRCP (UK) MSc (Evidence Based Medicine, UK) CCT (Respiratory and General Medicine UK), FCCP (USA), Diploma in Palliative Care (Newcastle University) Certificate in Education (Deeside University)Director & HoD Pulmonology, Fortis Hospital. Director, Research & Education, National Allergy Asthma Bronchitis Institute, Kolkata, India
Dr. Harjit Dumra
MBBS, MD (Internal Medicine)Consultant Interventional Pulmonologist Sleep Medicine and Critical Care Specialist Sterling Hospital Head, Dept of Critical Care, Sterling Hospital Director, Sparsh Chest Disease Center, Gujarat, India
Dr V. Rajesh
MBBS, MD, DNB, IDCCMBBS, MD, DNB, IDCC | HOD, Department of Pulmonary Medicine, Rajagiri Hospital, Kochi, IndiaResources
External Resources
Severe Asthma – Exploring the Role of Omalizumab
Also Read
Our Research
